The compounding pharmacies sector in the United States is witnessing notable growth due to increasing demand for personalized medications and rising prevalence of chronic illnesses. According to Expert Market Research, the United States compounding pharmacies market was valued at USD 7.00 billion in 2024. It is projected to grow at a CAGR of 6.30% during the forecast period 2025–2034, ultimately reaching a value of USD 12.90 billion by 2034.
United States Compounding Pharmacies Market Size
Compounding pharmacies play a crucial role in delivering customized medications when commercial drugs are not suitable for specific patient needs. This includes adjusting dosage strength, excluding allergens, or combining multiple medications into a single dose. The growing elderly population, rise in hormonal imbalance treatments, and increasing veterinary applications are expanding the market footprint.
The sector's growth is further bolstered by shortages in commercial drugs and heightened awareness about tailored treatments in functional medicine and integrative care.
United States Compounding Pharmacies Market Share
The market is primarily segmented by pharmacy type, with 503A compounding pharmacies catering to patient-specific prescriptions dominating the landscape. 503B outsourcing facilities, registered with the FDA and compliant with current good manufacturing practices (cGMP), are rapidly gaining momentum due to the increasing demand from hospitals and clinics for sterile compounded drugs.
Regionally, states like Texas, California, and Florida lead in market share, attributed to their robust healthcare infrastructure, higher aging populations, and presence of key market players.
Among the most influential companies in the U.S. compounding pharmacy market are:
Walgreen Co.
Empower Pharmacy
Valor Compounding Pharmacy, Inc.
Compounding Pharmacy of America
These players are investing heavily in automation, regulatory compliance, and expanding sterile compounding capacities.
United States Compounding Pharmacies Market Growth & Trends
Several growth drivers and emerging trends are shaping the U.S. compounding pharmacy market:
Personalized Medicine Adoption: Patients and healthcare providers are increasingly seeking tailored treatment solutions, especially for dermatology, hormone replacement therapy (HRT), and pediatrics.
Chronic Disease Burden: Rising incidence of chronic diseases, such as arthritis, hormone deficiencies, and pain disorders, is fueling demand for compounded medications.
Veterinary Applications: An expanding pet care industry is creating more demand for custom-formulated medications in animals.
Technological Advancements: Use of automated compounding systems and integration of electronic prescription platforms are improving operational efficiency.
Drug Shortages: Short-term shortages of commercially available drugs have opened up opportunities for compounding pharmacies to bridge supply gaps.
United States Compounding Pharmacies Market Case Studies & News
Empower Pharmacy opened a new 86,000-square-foot compounding facility in Houston, Texas, aiming to meet rising demand and adhere to FDA’s stringent quality regulations.
Triad Compounding Pharmacy announced a partnership with multiple hospitals to supply compounded sterile preparations (CSPs), reflecting growing institutional reliance on outsourcing facilities.
Valor Compounding Pharmacy recently launched an integrated e-prescribing platform for physicians, streamlining the custom medication process.
For a broader understanding of the historical and operational context of compounding practices, readers may refer to the Compounding entry on Wikipedia.
United States Compounding Pharmacies Market Analysis
The compounding pharmacy industry in the U.S. is heavily regulated by the U.S. Food and Drug Administration (FDA) and state pharmacy boards, especially concerning sterile compounding. The Drug Quality and Security Act (DQSA) of 2013 established distinctions between 503A and 503B pharmacies, tightening oversight and increasing quality standards.
While 503A pharmacies are more prevalent and focus on individual prescriptions, 503B facilities are expected to grow rapidly due to the convenience of producing bulk sterile medications for healthcare institutions.
However, regulatory scrutiny remains a challenge, requiring pharmacies to maintain strict documentation, risk mitigation procedures, and rigorous quality control systems.
United States Compounding Pharmacies Market Segmentation
By Product Type:
Oral Medication
Topical Medication
Injectable
Others
By Pharmacy Type:
503A Compounding Pharmacies
503B Compounding Pharmacies
By Compounding Type:
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Others
By Sterility:
Sterile
Non-sterile
By Therapeutic Area:
Hormone Replacement Therapy
Pain Management
Dermatology
Nutritional Supplements
Veterinary
Others
By Applications:
Adults
Geriatric
Veterinary
This comprehensive segmentation allows providers to address diverse patient needs, from pediatrics to geriatrics and even animal care.
United States Compounding Pharmacies Market Key Players
Walgreen Co.
US Drug Mart
Compounding Pharmacy of America
Triad Compounding Pharmacy
Valor Compounding Pharmacy, Inc.
Empower Pharmacy
These firms are leveraging innovation, partnerships, and compliance with cGMP standards to maintain leadership in a competitive and regulated market.
View More Reports
Osteoporosis Drug Pipeline Analysis Report
India Disposable Medical Gloves Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com